QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is Liraglutide?
Liraglutide is a glp-1 receptor agonist peptide. Long-acting GLP-1 analogue; activates GLP-1 receptors regulating insulin secretion, glucagon suppression, gastric emptying, and satiety signalling. Research use only.
Research Applications
GLP-1 Receptor Signalling
Receptor binding kinetics, cAMP pathway activation, downstream signalling
Metabolic Research
Insulin secretion regulation, glucagon suppression, glucose homeostasis
Satiety & Appetite Studies
Hypothalamic signalling, food intake reduction, energy balance models
Cardiovascular Research
Cardioprotective effects, MACE outcomes, endothelial function
Neuroprotection Studies
Neuroinflammation reduction, BDNF upregulation, cognitive function
Quick Specs
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 204656-20-2 |
| Molecular Formula | C₁₇₂H₂₆₅N₄₃O₅₁, MW 3751.2 |
| Identity | MS molecular weight confirmed — every batch |
| Peptide Type | GLP-1 Receptor Agonist Peptide |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (2–4 weeks) |
| Shelf Life | 24 months (unopened) |

